Back

Bleeding risk in all-comer TAVI patients

31 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Bleedings and conduction disturbances after aortic interventions Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Sivalaxmy Baleswaran Krishnapillai

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Impact of packed red blood cells administration on long-term outcomes in patients undergoing transcatheter aortic valve implantation
Doctor T. Stolte (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Assessing the CHA2DS2-VASc score in risk stratification and management of oral anticoagulation during TAVI
Doctor D. van Ginkel (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Bleeding risk stratification in patients undergoing transcatheter aortic valve replacement: enhancing VARC-HBR criteria with CT-ADP as a marker of primary hemostatic disorder
Doctor S. Kikuchi (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Impact of short membranous septal length on overall survival after transcatheter aortic valve replacement
Doctor H. Tsurumi (Okinawa, JP)
Abstract Slides Video
Presentation thumbnail
The impact of persistent LBBB After TAVI: unraveling its effect on cardiac function and survival
Doctor A. Lobo (Vila Nova de Gaia, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Bleedings and conduction disturbances after aortic interventions

The Event

Event poster

ESC Congress 2025

31 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Bleeding risk stratification in patients undergoing transcatheter aortic valve replacement: enhancing VARC-HBR criteria with CT-ADP as a marker of primary hemostatic disorder
thumbnail
Congress Session
Atrial fibrillation management and outcomes in high-risk atrial fibrillation populations
thumbnail
Congress Presentation
An external validation of DOAC score in patients with atrial fibrillation following transcatheter aortic valve replacement

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources